Objective: Various factors are known to determine the disease activity in patients with rheumatoid arthritis (RA). The 'simplified disease activity' index (SDAI) is new tool of measurement of disease activity. The present study was designed to assess validity of SDAI using C-reactive protein (CRP) titer in comparison to 'disease activity score in 28 joints' (DAS28) in Iraqi patients with active RA.
Introduction
Rheumatoid arthritis (RA) is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide [1] . Various factors are known to determine the disease activity in patients with RA [2] . Disease activity score in 28 joints (DAS28) is one of the standard methods that measure the disease activity in patients of RA [3, 4] ; its use in clinical practice is recommended by the European League Against Rheumatism (EULAR) [5] . DAS28 is calculated from the number of tender and swollen joint counts (TJC and SJC; 28-joint count), patient self-assessment of disease activity (visual analog scale, VAS), and erythrocyte sedimentation rate (ESR) according to the following formula [4] :
DAS28 = (0.56 • √[TJC]) + (0.28 • √[SJC]) + (0.7 • ln[ESR]) + (0.014 • VAS)
This formula requires complicated calculations, which mostly relay on using calculators. Simplified disease activity index (SDAI) is another instrument that has been validated in clinical practice to assess RA disease activity. The SDAI is calculated by adding up the SJC and the TJC in the same 28 joints used in the DAS28. These are added to the patient's global assessment, the physician's global assessment, and C-reactive protein (CRP). The SDAI has the advantage over the DAS28 in that the calculations are not as cumbersome, yet the performance of the SDAI is similar to the DAS28 [6] ; SDAI is the numerical sum of five outcome parameters: TJC and SJC (based on a 28-joint assessment), patient and physician global assessment of disease activity (VAS 0-10 cm) and level of CRP [7] ; this seems to be more simple and practical during clinical practice. Determination of the DAS28 in low or moderate ranges has critical importance because it determines the continuation or change in treatments, as well as the determination of whether the patient is in remission or is clinically active. Therefore, we design the present study to evaluate the mathematical and
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clinimetric properties of the DAS28 score, with special emphasis in all parts of its application range. The present study aims to compare the validity of SDAI when CRP measured by semi quantitative method to DAS28 for assessment of patients with active RA in the clinical settings.
Patients and methods
A cross-sectional study was conducted in Baghdad Teaching Hospital, Rheumatology Unit from August 2011 to January 2012. A total of 69 patients (11 males and 58 females) with active RA were involved in this study. Patients were diagnosed to have RA by the rheumatologist according to American College of Rheumatology (ACR) classification criteria for RA [8] . All patients included in the study signed an informed consent form according to the declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Baghdad University, College of Medicine, Department of Medicine. Patients with diseases other than rheumatoid arthritis were excluded from the study. Demographic data of patients were reported regarding their age, duration of the disease, and medication history ( Table 1) .
Evaluation of disease activity Disease activity was measured by DAS28 and the SDAI. The patients were clinically examined and the number of SJC (0-28) and TJC (0-28) were noted. The 28 joints included bilateral knees, shoulders, elbows, wrists, metacarpophalangeal and proximal interphalangeal joints. The patients were asked to mark on the VAS of 0-10 cm according to their global assessment of disease activity. The physician marked on the VAS of 0-10 cm according to the physician global assessment of the disease activity. Erythrocytes sedimentation rate was measured by Westergren method [9] , whereas CRP is measured semi-quantitatively using serial dilutions of serum; each dilution was mixed with a latex reagent and observed for the presence of agglutination [10] . Moreover, DAS was calculated from the TJC, SJC and ESR according to the following formula [4] : 
Statistical analysis
All data were statistically analyzed using Statistical Package for Social Sciences software version 18 (SPSS v.18); Chi square test for goodness of fit was used to test the significance of observed distribution of discrete variables, while Chi square test for independence was used to test the association between discrete variables; t-test was used for two independent samples and Mann Whitney test to test the significance of difference between two normally continuous samples. Pearson correlation coefficient was used to assess the correlation between continuous variables. Receiver operating characteristic (ROC) curve was used to assess the performance of a screening test at different levels, while κ statistics were used to assess the agreement between two tests. All p values used were asymptotic and two sided. Values with p < 0.05 were considered significant. Table 2 shows the values (mean ± SD) for the different studied variables, where significant differences reported between overall state of patients and classification into moderate or high severity stages. When the values of SDAI and DAS28 correlated, a highly positive and significant correlation was reported (r = 0.903, p < 0.001) (Fig.1) . Moreover, distribution of the study samples (classified as high and moderate disease activity) according to labeling with both DAS28 and SDAI was shown in table 3, where both approaches show good agreement of assessment values (κ = 0.777, p < 0.001).
Results
The validity of SDAI at different levels in detecting high disease activity as a screening test compared to DAS28 was evaluated, where a highly significant positive correlation was reported at most of the values greater than 1 (AUC = 0.983, p < 0.001), and evaluation of sensitivity and specificity of the two methods using ROC curve revealed a highly significant (p < 0.001) overlap for AUC in both methods (AUC = 0.975, Fig.2 ). κ* = 0.777, p < 0.001 DAS28, disease activity score-28; SDAI, simplified disease activity index; n, number of patients, *κ statistic for agreement between SDAI and DAS28 in detecting high disease activity.
Discussion
The popularity and importance of the DAS are evident not only because it is currently the most employed score in most of the clinical trials that involve drugs in rheumatoid arthritis (RA), but also because it has been included in several clinical practice guidelines (CPG) for treatment related decision making in patients with RA; especially to evaluate the need to start biologic therapy and for the evaluation of efficacy [11, 12] . When the validity of various disease activity indices are compared, the DAS28 is fond to be the best determinant of physician opinion, based on each physician's decision to modify the dose of drugs used in patients with RA [12] . However, other indices are available to measure RA activity on a continuous scale; in particular, the SDAI score which is simple to calculate and easy to use. SDAI, which is not developed to oppose the DAS (or DAS28) but only to provide rheumatologists with a simple tool [13] , exhibit similar validity to DAS, with the potential exception of the low disease activity ranges [11, 14] .
There is no exact definition of the concept of usefulness applied to indices for the follow-up of diseases. We already realized that evaluation of disease activity is useful when the results are close to the reality of what we intend to measure with the lowest cost and smallest investment possible. When questioning the usefulness of DAS28 or SDAI, we should ask two questions: (1) if the results approach the real disease activity, and (2) if the expense, both economical and temporal (time invested), is acceptable. It has been demonstrated that the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) [7, 15] , which are more simple than DAS calculation, can be considered as reliable as DAS; since they are simpler and they appear to be more suitable for routine employment [16] . The present study showed that both SDAI and DAS28 (a measure of the RA disease activity) appeared with a high degree of correlation as indicated by the Pearson's correlation coefficient (Fig.1) ; this seems consistent with that reported in another study, which states that DAS-ESR is correlated with SDAI [17] .
Despite the fact that we calculate CRP by semiquantitative method (can be easily affordable in our institutions) and not by the highly sensitive ELISA technique (hsCRP), the reproduced values supported the idea that the two approaches are correlated within this limit of sensitivity regarding CRP evaluation; such finding was found consistent with that reported by others, where both hsCRP and ordinary CRP are useful as diagnostic markers for myocardial infarction in patients with ischemic heart disease, though hsCRP is more sensitive in this respect [18] . However, this high degree of correlation between SDAI and DAS28, despite the less sensitive CRP value, can be explained since all patients with active RA have a high value of inflammatory markers, but this may not be the case in patients with RA who are in remission due to very low level of inflammatory markers [19] .
Other notable finding is the high level of agreement between disease activity when both categorized by either SDAI or DAS28 in Iraqi patients with active RA (Table 3) ; such result was also shown in a study that classify smaller proportions of patients as in remission by SDAI than by DAS28 criteria [20] , and also in another study in Indian patients that validated SDAI as a tool to assess the disease activity in comparison with DAS28 [21] . The present study also clarified that SDAI is valid as screening test, at different levels, in detecting high disease activity compared to DAS28 (Fig.2) ; such result also found consistent with those reported previously by others [7, 21] .
Recently, Balsa et al [22] have evaluated the proximity between composite indexes classifying patients in remission, utilizing the absence of activity detected by ultrasound as a gold standard; the results suggested that the SDAI definition of "remission" was closer to the concept of the absence of inflammatory activity, which is defined by the absence of a power Doppler signal in the ultrasound. Therefore, their results provide proof that current methods, such as DAS, are not necessarily indicators of true inflammatory remission, and could explain the progression of structural damage described in patients during clinical remission [22] .
It must finally be pointed out that the DAS score is an artifice with which we intend to weigh, with a single number, a complex clinical construct such as disease activity of RA. All simplifications have their limits and DAS is no exception. This type of combined score allows comparisons of different patients between them, sometimes with very distinct clinical characteristics, to be done with relative ease. It can be useful when comparing patient populations, such as the case of clinical trials, but becomes more problematic when used as the main parameter for the evaluation of individual patients, such as has recently been proven by Wolfe et al [23] . Even so, DAS28 represents an important leap in quality if we take into account that in the past the physician carried out the evaluation of the inflammatory activity of the disease in a purely subjective way.
While the literature supports that goal-directed treatments using validated instruments to assess disease activity results in improved patient outcomes, there are some limitations that should be recognized. First, the SJC and TJC in the above instruments assess only 28 joints. Notable exceptions to the joint evaluation are the feet, ankles and hips, which are commonly affected in RA. An additional limitation to be considered are potential confounders in the patient self-reported assessments of disease activity. For example, RA patients may have concomitant osteoarthritis, fibromyalgia or depression that could increase their self-assessment of disease activity, while not reflecting true activity of the inflammatory arthritis. Having other objective measures such as the ESR or CRP or the joint counts may help counter this potential bias. Finally, the consistency with which physicians derive their global assessments can also vary. The limitations may be overcomed by using more than 1 assessment tool and educating the patient on how other diseases could impact perceptions of pain and function. In conclusion, the SDAI is a valid and sensitive tool for assessment of RA disease activity, and found comparable with DAS28, even when semi-quantitative method is used to estimate CRP.
